{"id":24945,"date":"2026-10-01T10:57:08","date_gmt":"2026-10-01T10:57:08","guid":{"rendered":"https:\/\/www.drfz.de\/?p=24945"},"modified":"2026-10-01T11:02:36","modified_gmt":"2026-10-01T11:02:36","slug":"precision-therapy-against-disease-causing-plasma-cells","status":"publish","type":"post","link":"https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/","title":{"rendered":"Precision Therapy Against Disease-Causing Plasma Cells"},"content":{"rendered":"\n

Antibodies protect our body \u2013 but they can also attack it. Researchers at the German Rheumatology Research Center (DRFZ), a Leibniz Institute, and Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin have developed a new method to specifically remove the plasma cells that produce disease-causing antibodies. Plasma cells that protect the body and the rest of the immune system remain intact\u2014a promising approach for treating antibody-mediated diseases. The findings have now been published in the journal Proceedings of the National Academy of Sciences USA.<\/em><\/strong><\/p>\n\n\n\n

Antibodies protect us from many diseases, but they can also cause diseases themselves when they turn against the body. More than 10% of people in Germany are affected by such antibody-mediated diseases. Scientists at Charit\u00e9 and DRFZ, led by Prof. Falk Hiepe and Prof. Andreas Radbruch, have now developed a method to specifically remove the plasma cells that produce such pathogenic antibodies in these patients. These cells are killed by their own antibodies. Plasma cells that produce other, protective antibodies are not affected, and the patients\u2019 immune systems are not damaged\u2014unlike with currently available therapies.<\/p>\n\n\n\n

In a mouse model for systemic lupus erythematosus, the scientists were able to show that the selective removal of plasma cells that produce antibodies against DNA prevents kidney inflammation.  To do this, they developed a drug that binds a short segment of DNA on all plasma cells. When injected into mice, the plasma cells that secreted DNA-specific antibodies were killed by their own antibodies. The drug is a prototype of a new class of \u201cantibody-mediated cytotoxicity engagers\u201d (ACE), which could be used to specifically target and eliminate pathogenic plasma cells in other diseases as well. The key advantage of this new therapeutic approach is that the patients\u2019 immune systems remain intact, and only the pathogenic cells are eliminated.<\/p>\n\n\n\n

\n
\n

Original publication<\/h2>\n \n \n
\n \n
\n
\n \n Cheng Q, Khodadadi L, Jani PK, Sinzinger B, Klotsche J, Alexander T, Radbruch A, Hiepe F. Selective ablation of dsDNA-specific plasma cells improves lupus nephritis in NZB\/W mice. Proc Natl Acad Sci U S A. 2026 Sep 29;123(39):e2526826123. doi: 10.1073\/pnas.2526826123. Epub 2026 Sep 21. PMID: 42766751.<\/a>\n\n \n \n <\/span>\n <\/a>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/section>\n\n\n\n\n
\n
\n
\n

Scientists involved in the project<\/h2>\n \n <\/div>\n \n
\n \n\n
\n \"\" <\/div>\n
\n

Prof. Dr. med. Falk Hiepe<\/h2>\n
\n

\n Autoimmunology <\/p>\n Liaison working group with Charit\u00e9 – Rheumatology and Clinical Immunology<\/p>\n <\/div>\n <\/div>\n\n

\n

falk.hiepe@charite.de<\/a><\/p>\n <\/div>\n Prof. Dr. med. Falk Hiepe<\/span><\/a>\n<\/article>\n\n

\n \"\" <\/div>\n
\n

Prof. Dr. rer. nat. Andreas Radbruch<\/h2>\n
\n

\n Group leader: Cell Biology <\/p>\n <\/div>\n <\/div>\n\n

\n

radbruch@drfz.de<\/a><\/p>\n <\/div>\n Prof. Dr. rer. nat. Andreas Radbruch<\/span><\/a>\n<\/article>\n\n

\n \"\" <\/div>\n
\n

PD Dr. med. Tobias Alexander<\/h2>\n
\n

\n Leader: Programme Area 4, PA 4 \u2013 Translational Rheumatology <\/p>\n

\n Group leader: Autoimmunology <\/p>\n Liaison working group with Charit\u00e9 – Rheumatology and Clinical Immunology<\/p>\n <\/div>\n <\/div>\n\n

\n

tobias.alexander@charite.de<\/a><\/p>\n <\/div>\n PD Dr. med. Tobias Alexander<\/span><\/a>\n<\/article>\n\n

\n \"\" <\/div>\n
\n

Dr. Laleh Khodadadi<\/h2>\n
\n

Equal opportunities officer<\/p>\n <\/div>\n <\/div>\n\n

\n

gleichstellung@drfz.de<\/a><\/p>\n <\/div>\n Dr. Laleh Khodadadi<\/span><\/a>\n<\/article> <\/div>\n <\/div>\n <\/section>\n\n\n\n

Figure: Falk Hiepe & KI<\/p>\n","protected":false},"excerpt":{"rendered":"

Antibodies protect our body \u2013 but they can also attack it. Researchers at the German Rheumatology Research Center (DRFZ), a Leibniz Institute, and Charit\u00e9 \u2013\u2026<\/p>\n","protected":false},"author":4,"featured_media":24955,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[292,291],"tags":[639,455],"programme-area-tax":[179,182],"working-group-tax":[240],"class_list":["post-24945","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-publications","tag-andreas-radbruch-en","tag-radbruch-en","programme-area-tax-programme-area-1","programme-area-tax-programme-area-4","working-group-tax-autoimmunology"],"acf":[],"yoast_head":"\nPrecision Therapy Against Disease-Causing Plasma Cells - DRFZ<\/title>\n<meta name=\"description\" content=\"Scientists from DRFZ and Charit\u00e9 Berlin developed a novel precision therapy against disease-causing plasma cells\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Precision Therapy Against Disease-Causing Plasma Cells - DRFZ\" \/>\n<meta property=\"og:description\" content=\"Scientists from DRFZ and Charit\u00e9 Berlin developed a novel precision therapy against disease-causing plasma cells\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/\" \/>\n<meta property=\"og:site_name\" content=\"DRFZ\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/drfz.de\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-01T10:57:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-01T11:02:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/09\/261002_Andreas_Falk_Beitragsbild.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ute Hoffmann\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DRFZ_Berlin\" \/>\n<meta name=\"twitter:site\" content=\"@DRFZ_Berlin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ute Hoffmann\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/precision-therapy-against-disease-causing-plasma-cells\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/precision-therapy-against-disease-causing-plasma-cells\\\/\"},\"author\":{\"name\":\"Ute Hoffmann\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/person\\\/a86dc60d63c6fa52cb3ee62f12c72737\"},\"headline\":\"Precision Therapy Against Disease-Causing Plasma Cells\",\"datePublished\":\"2026-10-01T10:57:08+00:00\",\"dateModified\":\"2026-10-01T11:02:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/precision-therapy-against-disease-causing-plasma-cells\\\/\"},\"wordCount\":305,\"publisher\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/precision-therapy-against-disease-causing-plasma-cells\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/261002_Andreas_Falk_Beitragsbild.jpg\",\"keywords\":[\"Andreas Radbruch\",\"Radbruch\"],\"articleSection\":[\"News\",\"Publications\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/precision-therapy-against-disease-causing-plasma-cells\\\/\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/precision-therapy-against-disease-causing-plasma-cells\\\/\",\"name\":\"Precision Therapy Against Disease-Causing Plasma Cells - DRFZ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/precision-therapy-against-disease-causing-plasma-cells\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/precision-therapy-against-disease-causing-plasma-cells\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/261002_Andreas_Falk_Beitragsbild.jpg\",\"datePublished\":\"2026-10-01T10:57:08+00:00\",\"dateModified\":\"2026-10-01T11:02:36+00:00\",\"description\":\"Scientists from DRFZ and Charit\u00e9 Berlin developed a novel precision therapy against disease-causing plasma cells\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/precision-therapy-against-disease-causing-plasma-cells\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/precision-therapy-against-disease-causing-plasma-cells\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/precision-therapy-against-disease-causing-plasma-cells\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/261002_Andreas_Falk_Beitragsbild.jpg\",\"contentUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/261002_Andreas_Falk_Beitragsbild.jpg\",\"width\":1280,\"height\":720,\"caption\":\"Kunstbild zur Darstellung des Mechanismus\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/precision-therapy-against-disease-causing-plasma-cells\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Precision Therapy Against Disease-Causing Plasma Cells\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/\",\"name\":\"DRFZ\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#organization\",\"name\":\"Deutsches Rheuma-Forschungszentrum\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/drfz-footer-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/drfz-footer-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Deutsches Rheuma-Forschungszentrum\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/drfz.de\\\/\",\"https:\\\/\\\/x.com\\\/DRFZ_Berlin\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/deutsches-rheuma-forschungszentrum-berlin\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCf8nDuqpkWwcmCWmfSTkE3w\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/person\\\/a86dc60d63c6fa52cb3ee62f12c72737\",\"name\":\"Ute Hoffmann\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g\",\"caption\":\"Ute Hoffmann\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Precision Therapy Against Disease-Causing Plasma Cells - DRFZ","description":"Scientists from DRFZ and Charit\u00e9 Berlin developed a novel precision therapy against disease-causing plasma cells","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/","og_locale":"en_US","og_type":"article","og_title":"Precision Therapy Against Disease-Causing Plasma Cells - DRFZ","og_description":"Scientists from DRFZ and Charit\u00e9 Berlin developed a novel precision therapy against disease-causing plasma cells","og_url":"https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/","og_site_name":"DRFZ","article_publisher":"https:\/\/www.facebook.com\/drfz.de\/","article_published_time":"2026-10-01T10:57:08+00:00","article_modified_time":"2026-10-01T11:02:36+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/09\/261002_Andreas_Falk_Beitragsbild.jpg","type":"image\/jpeg"}],"author":"Ute Hoffmann","twitter_card":"summary_large_image","twitter_creator":"@DRFZ_Berlin","twitter_site":"@DRFZ_Berlin","twitter_misc":{"Written by":"Ute Hoffmann","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/#article","isPartOf":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/"},"author":{"name":"Ute Hoffmann","@id":"https:\/\/www.drfz.de\/en\/#\/schema\/person\/a86dc60d63c6fa52cb3ee62f12c72737"},"headline":"Precision Therapy Against Disease-Causing Plasma Cells","datePublished":"2026-10-01T10:57:08+00:00","dateModified":"2026-10-01T11:02:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/"},"wordCount":305,"publisher":{"@id":"https:\/\/www.drfz.de\/en\/#organization"},"image":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/#primaryimage"},"thumbnailUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/09\/261002_Andreas_Falk_Beitragsbild.jpg","keywords":["Andreas Radbruch","Radbruch"],"articleSection":["News","Publications"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/","url":"https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/","name":"Precision Therapy Against Disease-Causing Plasma Cells - DRFZ","isPartOf":{"@id":"https:\/\/www.drfz.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/#primaryimage"},"image":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/#primaryimage"},"thumbnailUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/09\/261002_Andreas_Falk_Beitragsbild.jpg","datePublished":"2026-10-01T10:57:08+00:00","dateModified":"2026-10-01T11:02:36+00:00","description":"Scientists from DRFZ and Charit\u00e9 Berlin developed a novel precision therapy against disease-causing plasma cells","breadcrumb":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/#primaryimage","url":"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/09\/261002_Andreas_Falk_Beitragsbild.jpg","contentUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/09\/261002_Andreas_Falk_Beitragsbild.jpg","width":1280,"height":720,"caption":"Kunstbild zur Darstellung des Mechanismus"},{"@type":"BreadcrumbList","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/precision-therapy-against-disease-causing-plasma-cells\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drfz.de\/en\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.drfz.de\/en\/news\/"},{"@type":"ListItem","position":3,"name":"Precision Therapy Against Disease-Causing Plasma Cells"}]},{"@type":"WebSite","@id":"https:\/\/www.drfz.de\/en\/#website","url":"https:\/\/www.drfz.de\/en\/","name":"DRFZ","description":"","publisher":{"@id":"https:\/\/www.drfz.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drfz.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.drfz.de\/en\/#organization","name":"Deutsches Rheuma-Forschungszentrum","url":"https:\/\/www.drfz.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.drfz.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/10\/drfz-footer-logo.svg","contentUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/10\/drfz-footer-logo.svg","width":1,"height":1,"caption":"Deutsches Rheuma-Forschungszentrum"},"image":{"@id":"https:\/\/www.drfz.de\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/drfz.de\/","https:\/\/x.com\/DRFZ_Berlin","https:\/\/www.linkedin.com\/company\/deutsches-rheuma-forschungszentrum-berlin","https:\/\/www.youtube.com\/channel\/UCf8nDuqpkWwcmCWmfSTkE3w"]},{"@type":"Person","@id":"https:\/\/www.drfz.de\/en\/#\/schema\/person\/a86dc60d63c6fa52cb3ee62f12c72737","name":"Ute Hoffmann","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g","caption":"Ute Hoffmann"}}]}},"_links":{"self":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts\/24945","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/comments?post=24945"}],"version-history":[{"count":3,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts\/24945\/revisions"}],"predecessor-version":[{"id":24961,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts\/24945\/revisions\/24961"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/media\/24955"}],"wp:attachment":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/media?parent=24945"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/categories?post=24945"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/tags?post=24945"},{"taxonomy":"programme-area-tax","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/programme-area-tax?post=24945"},{"taxonomy":"working-group-tax","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/working-group-tax?post=24945"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}